Dallas – September 21, 2026 -- Solidion Technology, Inc. (NASDAQ: STI) has combined its Chairman and CEO roles, appointing Jaymes Winters to the dual position effective September 16, 2026, while naming Mark N. Schwartz as Lead Independent Director.

San Rafael, Calif. – September 17, 2026 -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has appointed Robert Plenge, M.D., Ph.D., to its Board of Directors, effective September 10, 2026.